Formulation and Drug Delivery, Other

Pharmacovigilance Risk Assessment Committee Meeting Highlights

January 16, 2023

The members reviewed the measures to minimize the risk of serious side effects associated with Janus kinase (JAK) inhibitors used to treat several chronic inflammatory disorders.

Reformulating Success

October 02, 2022

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

Advances in Drug Delivery and Areas for Improvement

September 02, 2022

While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.

Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance a Treatment for Multiple Myeloma

March 18, 2022

Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.

Getting a Nose for Vaccines

October 02, 2021

The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.

Taking a Breath: Advances in Inhaled Biologics

April 02, 2021

The inhaled route of administration for biologics is experiencing renewed interest, particularly in light of the COVID-19 pandemic.

European Commission Approves Lynparza for BRCA-Mutated Metastatic Pancreatic Cancer

July 08, 2020

The European Commission has approved Lynparza (olaparib) for use in patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer within the European Union.

Former 3M Drug Delivery Systems Launches as Kindeva Drug Delivery

May 04, 2020

Kindeva Drug Delivery plans capital investment and jobs growth.

N4 Pharma Develops Nanoparticle Technology for Vaccine Delivery

March 01, 2019

The technology uses a silica nanoparticle to deliver vaccines and cancer treatments.

Nanoform Invests in Nanoparticle Technology for Drug Development

September 19, 2018

The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.